Patent Baristas

Well, here it is. The 120th Edition of Carnival of the Capitalists. Our hat tip to Jay Solo for letting the Baristas host this week. We have to admit, this was a very difficult task given the lack of sunlight around the Midwest in January – hence, our dire need for coffee. We’d rather just […]

In following the status of the reexamination request on Pfizer’s Viagra (sildenafil citrate) patent (U.S. Pat. No. 6,469,012), we find that Pfizer has filed a response to the outstanding Nonfinal Office Action. See the Nonfinal Office Action here. To recap, Pfizer filed a patent infringement lawsuit against ICOS, Lilly ICOS, and Lilly in the United […]

The U.S. Federal Trade Commission (FTC) is concerned about the recent use of anti-competitive drug patent deals in light of recent court rulings, which may spur drug companies to step up a practice of paying generic rivals to keep alternatives off the market. The FTC has filed a series of lawsuits challenging patent settlement agreements […]

We’ve been quite busy these days and so posting has been light as a result. Since I have a personal interest in getting my own workload reduced a little, I wanted to pass along that my firm is currently looking to hire on a few IP attorneys. The Position: Looking for a Patent Attorney with […]

The Food and Drug Administration (FDA) announced steps to advance the earliest phases of clinical research in the development of innovative medical treatments. This should make it easier for universities and small drug companies to test promising therapies in humans without having to pay the enormous amounts of expenditures normally required. In guidance documents released […]

A Frost and Sullivan report out says that the expiration of the Polymerase Chain Reaction (PCR) patent (US Patent No. 4,683,202) is setting the stage for growth opportunities for nucleic acid purification and amplification technologies. Companies can now offer tests without developing a novel nucleic acid technology or paying a license fee. The expiration of […]

Bruce MacEwen at Adam Smith, Esq. hosts a wonderful session of Blawg Review this week with a theme of Epiphany. We’re excited about anyone who knows that the 12 days of Christmas start the day after Christmas and end on Epiphany (there is that whole confusion over whether the Twelfth Night is on January 5th […]

One of the items I have trouble keeping up with is reporting on all the excellent law blogs that I come across. One recent addition to my RSS reader is Philip Brooks’ Patent Infringement Updates. This excellent blog provides insight into current events in patent infringement. There’s a whole category devoted to Patent Trolls (Peter […]